Go Pro

Jamie Clark Analyst Performance

Analyst at Roth Capital

Jamie Clark is a stock analyst at Roth Capital in the healthcare sector, covering 9 publicly traded companies. Over the past year, Jamie Clark has issued 8 stock ratings, including buy and hold recommendations. While full access to Jamie Clark's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jamie Clark's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
15 Last 1 Years
Buy Recommendations
54.55% 6 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy54.5%6 ratings
Hold45.5%5 ratings
Sell0.0%0 ratings

Out of 11 total stock ratings issued by Jamie Clark at Roth Capital, the majority (54.5%) have been Buy recommendations, followed by 45.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
55.6% of companies on NASDAQ
5 companies
NYSE
44.4% of companies on NYSE
4 companies

Jamie Clark, an analyst at Roth Capital, currently covers 9 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
9 companies
100.0%

Jamie Clark of Roth Capital specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE PROVIDERS & SERVICES
4 companies
44.4%
LIFE SCIENCES TOOLS & SERVICES
3 companies
33.3%
BIOTECHNOLOGY
1 company
11.1%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
11.1%

Jamie Clark's Ratings History at Roth Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Tempus AI, Inc. stock logo
TEM
Tempus AI
9/8/2026Initiated Coverage$64.62$67.00Neutral
Icon Plc stock logo
ICLR
Icon
2/17/2026Set Price Target$93.00$100.00Neutral
Icon Plc stock logo
ICLR
Icon
2/17/2026Downgrade$88.62$100.00Neutral
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
9/15/2025Set Price Target$257.73$311.00
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
9/15/2025Initiated Coverage$253.50$311.00Buy
IQVIA Holdings Inc. stock logo
IQV
IQVIA
9/3/2025Set Price Target$181.48$214.00
Icon Plc stock logo
ICLR
Icon
9/3/2025Upgrade$177.84$236.00Buy
Medpace Holdings, Inc. stock logo
MEDP
Medpace
9/3/2025Downgrade$473.34$474.00Neutral
IQVIA Holdings Inc. stock logo
IQV
IQVIA
5/23/2025Set Price Target$136.96$188.00
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4/2/2025Set Price Target$159.16$195.00
Labcorp Holdings Inc. stock logo
LH
Labcorp
4/2/2025Initiated Coverage$232.63$276.00Buy
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
4/2/2025Initiated Coverage$169.45$195.00Buy